INHIBITION BY SOMATOSTATIN OF BASAL LEVELS OF SERUM THYROTROPIN (TSH) IN NORMAL MEN

被引：110

作者：

WEEKE, J ^{[1
]}

HANSEN, AP ^{[1
]}

LUNDAEK, K ^{[1
]}

机构：

[1] UNIV AARHUS, KOMMUNE HOSP, CLIN INTERN MED 2, AARHUS, DENMARK

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1975年 / 41卷 / 01期

关键词：

D O I：

10.1210/jcem-41-1-168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：168 / 171

页数：4

共 24 条

[1]

ALBERTI KGM, 1973, LANCET, V2, P1299

[2]

ALFORD FP, 1974, LANCET, V2, P974

[3]

BLOOM SR, 1974, LANCET, V2, P1106

[4] SOMATOSTATIN AS A TOOL IN STUDIES OF BASAL CARBOHYDRATE AND LIPID-METABOLISM IN MAN - MODIFICATIONS OF GLUCAGON AND INSULIN RELEASE [J].

CHRISTENSEN, SE ;

HANSEN, AP ;

IVERSEN, J ;

LUNDBAEK, K ;

ORSKOV, H ;

SEYERHANSEN, K .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1974, 34 (04) :321-325

[5] ACUTE SUPPRESSION OF INSULIN AND GLUCOSE LEVELS BY SYNTHETIC SOMATOSTATIN IN NORMAL HUMAN SUBJECTS [J].

DEVANE, GW ;

SILER, TM ;

YEN, SSC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (05) :913-915

[6] EFFECTS OF SOMATOSTATIN ON PLASMA GLUCOSE AND GLUCAGON LEVELS IN HUMAN DIABETES-MELLITUS - PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS [J].

GERICH, JE ;

LORENZI, M ;

SCHNEIDER, V ;

KARAM, JH ;

RIVIER, J ;

GUILLEMIN, R ;

FORSHAM, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (11) :544-547

[7]

HALL R, 1973, LANCET, V2, P581

[8]

HANSEN AE, IN PRESS

[9]

HANSEN AP, 1974, OCT INT SOC NEUR SER

[10]

HILL DE, 1973, EXCERPTA MEDICA 280, P66

← 1 2 3 →